Archive: EU MDR

New biopharma and medical device regulations

Tags: , , ,

This article highlights some notable regulatory initiatives that will impact the biopharmaceutical and medical device industry over the coming years. We explore why these are being rolled out, what the impact on industry will be, where the potential challenges are and how value can be realized from these efforts. ... Read more.

publication date: 2017-09

EY refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global EY organization and does not provide any service to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms